Who are we ?

Poietis is a biotechnology company whose mission is to support Researchers and Physicians in the emergence of personalized medicine by providing innovative solutions based on 4D Bioimprinting technology of biological tissues .

Incubated in the Incubateur Régional d''Aquitaine (Aquitaine Regional Incubator) between 2012 and 2014, and winner of the 2014 ILab Contest (French National Competition for Innovative start-up Creation of the Ministry of Research, Creation-Development category), Poietis is the result of nearly ten years of research at the INSERM and the Bordeaux University on the development of new approaches of tissue engineering.

As a young and innovative company, Poietis, created in September 2014, obtained from the University of Bordeaux, INSERM and the SATT Aquitaine Science Transfert® office the exclusive worldwide license on patents associated with the Laser-Assisted Bioimprinting technology (more info here).


2005 .
Beginning of the Bioprinting project in Biomaterials Laboratory and Tissue Repair (INSERM - University of Bordeaux).
2006 .
First cells bioprinted by Laser.
2006 – 2009 .
Project LasEncaps funded by the Aquitaine Region.
2007 .
Construction of the first 3D Laser-Bioimprinter (in a partnership with NovaLase).
2008 .
Launch of a research program on the modelization of droplet ejection mechanism by Laser (collaboration with the CELIA Laboratory).
2009 .
Organization of the International Congress and Bioprinting and Biofabrication in Bordeaux (3B'09).
2010 – 2011 .
Publication in Biofabrication of an article describing the proof of concept of 3D Bioprinting in vivo; publications in Nanomedecine, Acta Biomaterialia, Biomaterials, Trends in Biotechnology.
2011 .
Winner of the "Idée à créer" Aquitaine Valo Contest
2010 – 2013 .
LASIT Project funded by the Aquitaine Region.
2010 – 2014 .
Bone Printing Project funded by the French National Research Agency (ANR TecSan).
2012 .
Winner of the French National Competition of Innovative start-ups (category "emerging", Project LA Fabric) .
2013 .
Creation of the second3D Laser-Bioprinter (partnership with Alphanov).
2014 .
Winner of the National Competition I-LAB 2014
Innovation Showroom Winner Bordeaux Unitec
Inception of Poietis
Installation at the Bordeaux Metropole Bioparc.
2015 .
Firsts contracts signed with industries
Successful crowdfunding via Wiseed.
2016 .
Phase 1 Winner of the CMI (Concours Mondial d'Innovation in the "Personalized Medecine" category.


Fabien Guillemot

Fabien Guillemot, PhD

Founder & CEO

Chief Scientific Officer

Fabien has an over 15 years experience in the field of regenerative medicine.

He holds a PhD in Science from INSA, the National Institute of Materials and Applied Sciences, of Rennes (2000) and a habilitation to lead Research in Health and Life Sciences issued by Bordeaux Segalen University (2010). Fabien was appointed Researcher at INSERM in 2005 and was also Guest Researcher at Harvard University in 2010 in the Cell and Tissue Engineering Laboratory. He also has completed its scientific training by entrepreneurship education provided to HEC (Challenge + program) in 2012-2013.

Fabien has initiated pioneering work internationally in the field of bioprinting and published over 20 scientific articles and directed more than 50 invited lectures on this new technology.

Bruno Brisson

Bruno Brisson

Co-Founder & General Manager

Chief Business Officer

Scientific by training (M.Sc) Bruno has a professional experience of over 20 years in biotechnologies.

After beginning his career in biochemistry and technology transfer, he worked in the US especially as a Research Associate and Analyst within a consulting firm based in Chicago, IL. He returned to France in 2001 for launching a biotech start-up incubator and then held various positions in Business, Sales&Marketing (Cellectis, Mauna Kea Technologies, Fluofarma) and management (President and CEO of Biospace Lab).

With his experience Bruno created his company, BLS consulting, in 2011 and accompanied more than fifteen biotech/medtech companies for business and corporate development in preclinical research and dermocosmetics.

Bertrand Viellerobe

Bertrand Viellerobe, PhD

Chief Technology Officer

Bertrand has 17 years of experience in the photonics field. He graduated from the University of Bordeaux with a Ph.D. in Physics obtained in 2000 on the near-field optical microscopy for the detection of single molecules.

Before joining Poietis, Bertrand worked 10 years at Mauna Kea Technologies (listed company based in Paris) as R&D Manager to develop the most miniaturized microscope in the world dedicated to medical imaging in vivo. Bertrand then joined the Cluster “Route des Lasers®” (Bordeaux) as a Project Director. For 4 years he has accompanied and certified over 220 photonics projects. Bertrand has published 25 articles and is co-inventor of 13 patents. .

Delphine Fayol

Delphine Fayol, PhD

Chief Products Officer

Delphine is an Engineer from École Polytechnique and a graduate of Cornell University Materials Science. She also completed a PhD in tissue engineering at the laboratory “Matière et Systèmes Complexes” of the University Paris 7 (UMR 7057). Her thesis focused on methods for creating tissue structures from stem cells and biomaterials and resulted in four publications and a patent.

Before joining Poietis, Delphine worked at Bertin Technologies on industrialization projects of stem cell culture processes for autologous cardiac therapy. She also followed the 2014 Stanford Ignite Europe, an Entrepreneurship and Innovation Programme of the Stanford Business School.